Codexis introduced the Codex MicroCyp Plate, a research productivity tool which can be used by pharmaceutical companies to more rapidly identify and synthesize drug metabolites and novel drug lead candidates.

University students in America are turning to amphetamine-based prescription medications in overwhelming numbers to boost their focus, stay up late, and cram for finals. These meds, most often prescribed for Attention Deficit Hyperactivity Disorder (ADHD), can improve concentration but may also pose serious health risks.

FDA has approved Astellas Pharma's sNDA seeking approval for the use of MYCAMINE for Injection in the treatment of patients with Candidemia, Acute Disseminated Candidiasis, Candida Peritonitis and Abscesses.